title: Can biomarkers of disease activity guide treatment in FSGS?
authors.affiliation: Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York.
authors.forename: Kirk N
authors.initials: KN
authors.lastname: Campbell
authors.affiliation: Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York cijiang.he@mssm.edu.
authors.forename: John C
authors.initials: JC
authors.lastname: He
mesh_terms: D005260:Female; D005923:Glomerulosclerosis, Focal Segmental / Q000235:genetics* / Q000652:urine*; D006801:Humans; D008297:Male; D035683:MicroRNAs / Q000652:urine*
chemical_list: C542543:MIRN196 microRNA, human; C546086:MIRN30b microRNA, human; C574862:MIRN490 microRNA, human; D035683:MicroRNAs
keywords: focal segmental glomerulosclerosis; glomerular disease; pathology
references.citation: Mol Biol Rep. 2010 Jul;37(6):2951-8
references.pmid: 19821056
references.citation: N Engl J Med. 2011 Dec 22;365(25):2398-411
references.pmid: 22187987
references.citation: Nat Genet. 2000 Mar;24(3):251-6
references.pmid: 10700177
references.citation: J Am Soc Nephrol. 2014 Jan;25(1):92-104
references.pmid: 24029422
references.citation: Microsc Res Tech. 2002 May 15;57(4):189-95
references.pmid: 12012382
references.citation: Nucleic Acids Res. 2009 Jan;37(Database issue):D98-104
references.pmid: 18927107
references.citation: Expert Opin Pharmacother. 2009 Mar;10(4):615-28
references.pmid: 19284364
references.citation: Contrib Nephrol. 2013;181:109-18
references.pmid: 23689573
references.citation: Cell. 2009 Jan 23;136(2):215-33
references.pmid: 19167326
references.citation: Protein Cell. 2013 Nov;4(11):813-9
references.pmid: 24214874
references.citation: Int J Mol Sci. 2013 Jun 25;14(7):13078-92
references.pmid: 23799361
references.citation: Cell. 2009 Feb 20;136(4):642-55
references.pmid: 19239886
references.citation: Pediatr Nephrol. 2013 Sep;28(9):1797-801
references.pmid: 23463342
references.citation: J Am Soc Nephrol. 2008 Nov;19(11):2150-8
references.pmid: 18776121
references.citation: Nefrologia. 2013;33(4):448-61
references.pmid: 23897176
references.citation: Semin Nephrol. 2003 Mar;23(2):117-34
references.pmid: 12704572
references.citation: J Am Soc Nephrol. 2005 Oct;16(10):2941-52
references.pmid: 16107576
references.citation: Urol Oncol. 2010 Nov-Dec;28(6):655-61
references.pmid: 19375957
references.citation: Expert Rev Hematol. 2012 Dec;5(6):579-81
references.pmid: 23216588
references.citation: Nephrology (Carlton). 2010 Sep;15(6):599-608
references.pmid: 20883280
references.citation: Nat Genet. 2000 Apr;24(4):349-54
references.pmid: 10742096
references.citation: Semin Nephrol. 2003 Mar;23(2):141-6
references.pmid: 12704574
references.citation: Nat Rev Genet. 2004 Jul;5(7):522-31
references.pmid: 15211354
references.citation: Clin J Am Soc Nephrol. 2014 Sep 5;9(9):1545-52
references.pmid: 25107948
references.citation: Mol Cell. 1998 Mar;1(4):575-82
references.pmid: 9660941
references.citation: Development. 2010 Apr;137(7):1107-16
references.pmid: 20215348
references.citation: J Am Soc Nephrol. 2008 Nov;19(11):2159-69
references.pmid: 18776119
references.citation: Am J Transplant. 2011 Oct;11(10):2221-7
references.pmid: 21812927
references.citation: Nat Med. 2013 Apr;19(4):481-7
references.pmid: 23502960
references.citation: FASEB J. 2008 Dec;22(12):4126-35
references.pmid: 18716028